Abstract
Objective
Heart failure treatment in general practice is not concordant with guideline recommendations. Insight into the key determinants at different levels is needed in order to improve care. The aim was to assess the influence of physician, organisational and patient characteristics on the treatment of chronic heart failure with angiotensin converting enzyme (ACE) inhibitors in primary care.
Methods
Physician and organisational data were collected by means of a questionnaire. Patient and treatment data were extracted from electronic medical records. Multilevel analysis was used to assess the effect of physician, organisational and patient factors on the treatment with ACE inhibitors in terms of prescription rate and dosage.
Results
Data from 735 randomly selected heart failure patients were extracted from the medical records of 95 general practitioners (GPs). Patients who visited a cardiologist or an outpatient heart failure clinic were more likely to receive an ACE inhibitor. In addition, relatively young patients, male patients and patients already using a diuretic were more likely to receive an ACE inhibitor. Furthermore, male patients and patients with concomitant hypertension were more likely to receive a higher dose of ACE inhibitor. GP characteristics did not determine whether CHF patients received ACE inhibitor treatment.
Conclusion
The differences in ACE inhibitor prescribing seem to be linked more to patient than physician characteristics. Interventions to improve the quality of care should therefore focus on the treatment of specific patient groups. Specialised care, particularly through outpatient clinics, could lead to improvement in the use of ACE inhibitors.
Similar content being viewed by others
References
Kulig M, Erika S, Norbert WS (2003) Comparing methodological quality and consistency of international guidelines for the management of patients with chronic heart failure. Eur J Heart Fail 5(3):327–335
Walma EP, Bakx HCA, Besseling RAM, Hamstra PWJ et al (1995) Dutch College of General Practitioners Guidelines of Heart failure (NHG-standaard hartfalen). Huisarts Wet 38:471–487
Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360(9346):1631–1639
Nilsson G, Strender LE (2002) Management of heart failure in primary health care. A retrospective study on electronic patient records in a registered population. Scand J Prim Health Care 20(3):161–165
Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A et al (2003) The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24(5):464–474
Pont LG, Sturkenboom MC, Van Gilst WH, Denig P, Haaijer-Ruskamp FM (2003) Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000. Pharmacoepidemiol Drug Saf 12(4):327–334
Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4(6):771–777
Hickling JA, Nazareth I, Rogers S (2001) The barriers to effective management of heart failure in general practice. Br J Gen Pract 51(469):615–618
Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326(7382):196
Horne R, Coombes I, Davies G, Hankins M, Vincent R (1999) Barriers to optimum management of heart failure by general practitioners. Br J Gen Pract 49(442):353–357
Edep ME, Shah NB, Tateo IM, Massie BM (1997) Differences between primary care physicians and cardiologists on management of congestive heart failure: relation to practice guidelines. J Am College Cardiol 30:518–526
Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5(3):337–344
Akosah KO, Schaper AM, Havlik P, Barnhart S, Devine S (2002) Improving care for patients with chronic heart failure in the community: the importance of a disease management program. Chest 122(3):906–912
Mejhert M, Holmgren J, Wandell P, Persson H, Edner M (1999) Diagnostic tests, treatment and follow-up in heart failure patients—is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1(4):407–410
Johansson S, Wallander MA, Ruigomez A, Garcia R (2002) Treatment patterns among newly diagnosed heart failure patients in general practice. Eur J Clin Pharmacol 57(11):813–817
Hood S, Taylor S, Roeves A, Crook AM, Tlusty P, Cohen J et al (2000) Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract 50(456):559–563
Ahmed A, Allman RM, Kiefe CI, Person SD, Shaneyfelt TM, Sims RV et al (2003) Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care. Am Heart J 145(6):1086–1093
Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BHR, Haaijer-Ruskamp FM (2004) Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care. Diabetes Care 27(1):123–128
Luzier AB, Forrest A, Adelman M, Hawari FI, Schentag JJ, Izzo JL Jr (1998) Impact of angiotensin-converting enzyme inhibitor under dosing on rehospitalization rates in congestive heart failure. Am J Cardiol 82(4):465–469
Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Perceived barriers for treatment of chronic heart failure in general practice. Are they affecting performance? BMC Fam Pract submitted.
Snijders T, Bosker R (2002) Multilevel analysis. An introduction to basic and advanced multilevel modeling, 2nd edn. SAGE, London
Khunti K, Baker R, Grimshaw G (2000) Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. Br J Gen Pract 50(450):50–54
McColl A, Roderick P, Smith H, Wilkinson E, Moore M, Exworthy M et al (2000) Clinical governance in primary care group: the feasibility of deriving evidence-based performance indicators. Qual Health Care 9:90–97
NHS Quality indicators (2004) Available at: http://www.nhsconfed.org/docs/annex_a_quality_indicators.doc
Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW et al (2000) Team management of patients with heart failure—a statement for healthcare professionals from the Cardiovascular Nursing Council of the American Heart Association. Circulation 102(19):2443–2456
Sparrow N, Adlam D, Cowley A, Hampton JR (2003) The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail 5:349–354
Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA et al (2000) Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med 160(1):53–60
Shah MR, Granger CB, Bart BA, McMurray JJV, Petrie MC, Michelson EL et al (2000) Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med 109(6):489–492
Manyemba J, Mangoni A, Pettingale K, Jackson S (2003) Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure. Eur J Heart Fail 5(5):693–696
Pont LG, van Gilst WH, Lok DJ, Kragten HJ, Haaijer-Ruskamp FM (2003) Dutch working group on heart failure. The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. Eur J Heart Fail 5(2):187–193
Acknowledgements
The authors wish to thank the GPs for their time and participation in this study. The study was financially supported by the Dutch Ministry of Health, Well-being and Sports through a regional organisation aimed at the implementation of joint treatment guidelines.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasje, W.N., Denig, P., Stewart, R.E. et al. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study. Eur J Clin Pharmacol 61, 145–151 (2005). https://doi.org/10.1007/s00228-005-0897-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0897-6